癌症缓冲症:专注于缓冲症因素和器官间通信
Yongfei Wang1,2, Zikai Dong1,2, Ziyi An1,2
1The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China.
Chinese medical journal
|November 15, 2023
概括
癌症缓存症是一种复杂的综合征,涉及通过癌症缓存因子中断器官间的通信. 了解这些因素是开发这种疾病的新诊断和治疗策略的关键.
科学领域:
- 在瘤学瘤学.
- 系统生物学 系统生物学
- 内分泌学 在内分泌学.
背景情况:
- 癌症缓冲症是一种衰弱的多器官综合征,其特点是复杂的器官间信号传输.
- 驱动缓冲症发病的精确机制在很大程度上是未知的,这阻碍了有效的治疗开发.
- 目前的治疗方法往往专注于单个分子或器官,忽视了更广泛的瘤生态系统.
研究的目的:
- 提供癌症缓解症病原,诊断和治疗的全面概述.
- 突出癌症缓冲因子在器官间信号通信中的作用.
- 为了强调需要瘤生态系统的角度在缓解症研究.
主要方法:
- 关于癌症缓解因子的现有文献的综述.
- 分析瘤,宿主细胞和器官之间的信号通信通路.
- 综合当前关于病原,诊断和治疗点的知识.
主要成果:
- 癌症缓解症因子是缓解症中信号通信的关键媒介.
- 这些因素源于瘤和宿主细胞的相互作用.
- 一种多器官,瘤生态系统的方法对于推进缓冲症管理至关重要.
结论:
- 全面了解癌症缓冲因子及其在器官间沟通中的作用至关重要.
- 这种知识可以带来更好的诊断工具和更有效的癌症缓存症治疗方法.
- 需要进一步研究瘤生态系统对缓冲症的影响.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
What is Cancer?
10.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


